Position in GILD
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$119,738,606
-$6,571,726 QoQ
Shares Held
947,749
+4.6% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#129
of 2,266 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Dec 31, 2020CallValue
$8,739,000
CallShares
150,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vontobel Holding Ltd. holds $908,993,306 across 12 Drug Manufacturers - General names. GILD ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,300,930 | $330,397,188 | |
| 2 | LLY |
ELI LILLY & Co
|
136,320 | $163,506,307 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
947,749 | $119,738,606 | |
| 4 | AZN |
Astrazeneca PLC
|
346,381 | $65,680,764 | |
| 5 | AMGN |
Amgen Inc
|
155,115 | $56,170,241 | |
| 6 | ABBV |
AbbVie Inc.
|
198,110 | $49,852,399 | |
| 7 | MRK |
Merck & Co., Inc.
|
385,052 | $49,479,181 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
725,587 | $41,808,321 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $119,738,606 | 947,749 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $126,310,332 | 906,295 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $85,639,501 | 697,731 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $66,584,460 | 599,860 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $22,760,832 | 205,293 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $25,671,885 | 229,111 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $20,171,943 | 218,382 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $21,724,200 | 259,115 | Shares | Defined | 2024-10-16 | |
| 2024-06-30 | $18,010,260 | 262,502 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $21,784,841 | 297,404 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $21,168,963 | 261,313 | Shares | Defined | 2024-06-04 | |
| 2023-09-30 | $18,559,638 | 247,660 | Shares | Defined | 2024-06-04 | |
| 2023-06-30 | $18,036,612 | 234,029 | Shares | Defined | 2024-06-04 | |
| 2023-03-31 | $13,341,906 | 160,804 | Shares | Defined | 2024-06-04 | |
| 2022-12-31 | $12,645,961 | 147,303 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,777,061 | 158,487 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $9,659,912 | 156,284 | Shares | Defined | 2022-07-27 | |
| 2022-03-31 | $9,874,822 | 166,103 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $12,246,547 | 168,662 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $20,014,887 | 286,541 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $28,489,102 | 413,725 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $29,054,221 | 449,547 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $8,739,000 | 150,000 | Call | Defined | 2021-02-12 | |
| 2020-12-31 | $30,490,195 | 523,347 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||